Supernus Pharmaceuticals Aktie

Kaufen

Verkaufen

Handeln Handeln

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

28,80 EUR +1,00 EUR +3,60 %

08:01:30

FSE

33,56 USD -0,04 USD -0,12 %

15:58:29

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.1,60 Mrd. EUR

KGV27,39Div. Rendite0,00%

WKNA1JX3U

ISINUS8684591089

SymbolSUPN

Supernus Pharmaceuticals Aktien News

Sortieren:Datum Meistgelesen

17.06.25ZacksSAGE to be Acquired by Supernus Pharmaceuticals in $795 Million Deal

16.06.25PR NewswireALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.

14.05.25ZacksIs the Options Market Predicting a Spike in Supernus Pharmaceuticals (SUPN) Stock?

WerbungSupernus Pharmaceuticals-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

06.05.25ZacksSupernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Surpass Estimates

25.02.25ZacksSupernus Pharmaceuticals (SUPN) Beats Q4 Earnings and Revenue Estimates

19.02.25BenzingaSupernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial

05.11.24ZacksSupernus Pharmaceuticals (SUPN) Beats Q3 Earnings and Revenue Estimates

11.09.24BenzingaADHD Drug Maker Supernus Pharmaceuticals Downgraded On Slower Prescription Growth For Its Top-Selling Drug

07.08.24ZacksSupernus Pharmaceuticals (SUPN) Misses Q2 Earnings Estimates

23.05.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

17.05.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

07.05.24PR NewswireM8 Pharmaceuticals, an Acino company, signs an exclusive licensing agreement with Supernus for Qelbree® (Viloxazine XR) in Latin America

07.05.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

28.04.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

20.04.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

04.11.22PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

27.10.22PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

Supernus Pharmaceuticals News

Supernus Pharmaceuticals News: auf dieser Seite finden Sie alle Supernus Pharmaceuticals News und Nachrichten zur Supernus Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Supernus Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Supernus Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.